Geron reported $70.33M in Current Liabilities for its fiscal quarter ending in June of 2026.





Current Liabilities Change Date
Amgen USD 25.5B 547M Jun/2026
Bio Techne USD 163.7M 10.42M Jun/2026
Cassava Sciences USD 40.11M 3.72M Mar/2026
Cytokinetics USD 181.43M 17.76M Jun/2026
Exelixis USD 361.93M 9.05M Jun/2026
Genmab DKK 1.14B 38M Jun/2026
Geron USD 70.33M 3.24M Jun/2026
Gilead Sciences USD 11.02B 1.54B Jun/2026
Incyte USD 1.31B 177.55M Jun/2026
MacroGenics USD 108.82M 12.88M Jun/2026
Novartis USD 31.75B 374M Jun/2026
Novavax USD 330.57M 11.89M Jun/2026